Industry specialization Bluprint Oncology—Powered by Petauri operates in medical strategy and communications with a focus on oncology and hematology, indicating a strong alignment with pharma and biotech sales opportunities seeking specialized communications support and medical storytelling.

Mid-market potential With 51-200 employees and a revenue range of 50M to 100M, Bluprint Oncology sits in a mid-market segment that often seeks scalable, specialized external partners for campaigns, digital media, and patient/ clinician-focused storytelling.

Tech-driven reach Leveraging LinkedIn Ads, AWS, Google Cloud, and other digital platforms suggests readiness for demand-gen programs, data-backed content distribution, and scalable digital campaigns to reach oncology and hematology audiences.

Parent platform leverage As part of Petauri Advance, Bluprint benefits from a broader medical communications ecosystem, enabling cross-sell of services such as medical affairs, HEOR, patient services, and analytics to existing or prospective pharma clients.

Proven storytelling niche Deep experience spanning from traditional chemotherapies to immuno-oncology provides a unique narrative capability to support clinical data storytelling, potentially winning partnerships with firms seeking compelling dissemination across conferences, journals, and social channels.